Biotech

Alzheimer’s disease is a disease that very difficult to detect early. A doctor suggests patients are suffered the disease untill the doctor find that they get mild memory loss which it then tend to worst conditions.

However, researchers at the University of Pennsylvania had claimed that their diagnosis method could detect Alzheimer’s disease symptoms earlier than mild cognitive impairment. They used a scan combination of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI). PET is used to get real time measurement of blood flow in the brain. MRI is used to show the shape and size of physical structures in the brain.

“This abnormal pattern of brain structure and blood flow detected not only mild cognitive impairment but even earlier … when they were clinically normal,” said the researcher.

Popularity: 43%